Calpain is a mediator of myocardial injury in experimental uremia: Is it activated by endogenous ouabain?

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Harwood, Steven M ^a   Allen, David A ^a   Raftery, Martin J ^a   Yaqoob, Muhammad M ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Calpain; LVH; Ouabain

Indexed keywords

CALCIUM ION; CALPAIN; OUABAIN; CARDENOLIDE; CARDIOTONIC AGENT; DIGOXIN; DIGOXIN LIKE FACTORS; DIGOXIN-LIKE FACTORS; SAPONIN;

CALCIUM TRANSPORT; CELL TRANSPORT; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; EXTRACELLULAR SPACE; GENE ACTIVATION; HEART INJURY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; KIDNEY FUNCTION; MEDIATOR RELEASE; MYOBLAST; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; UREMIA; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM;

CALPAIN; CARDENOLIDES; CARDIOTONIC AGENTS; CELLS, CULTURED; DIGOXIN; ENZYME ACTIVATION; HUMANS; MYOBLASTS, CARDIAC; OUABAIN; SAPONINS; UREMIA;

EID: 0037407673     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.48.x     Document Type: Conference Paper

References (20)

1. RAINE AE, MARGREITER R, BRUNNER FP, et al: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7:7-35, 1992
2. SILBERBERG JS, BARRE PE, PRICHARD SS, SNIDERMAN AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kid Int 36:286-290, 1989
3. MCMAHON AC, VESCOVO G, DALLA LIBERA L, et al: Contractile dysfunction of isolated ventricular myocytes in experimental uraemia. Exp Nephrol 4:144-150, 1996
4. AMANN K, RITZ E: Cardiac disease in chronic uremia: Pathophysiology. Adv Ren Replace Ther 4:212-224, 1997
5. HUANG Y, WANG KKW: The calpain family and human disease. TRENDS Mol Med 7:355-362, 2001
6. ARTHUR GD, BELCASTRO AN: A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol Cell Biochem 176:241-248, 1997
7. ALMAZOV VA, SHLYAKHTO EV, KONRADY AO, et al: Corrective of hypertensive cardiac remodeling: Comparison of different antihypertensive therapies. Med Sci Monit 6:309-313, 2000
8. HARWOOD SM, ALLEN DA, CHESSER AMS, et al: Calpain is activated in experimental uremia: Is calpain a mediator of uremia induced myocardial injury? Kid Int
9. SCHONER W: Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269:2440-2448, 2002
10. NARUSE K, NARUSE M, TANABE A, et al: Does plasma immunoreactive ouabain originate from the adrenal gland? Hypertension 23[Suppl I]:I-102-I-105, 1994.
11. HARWOOD S, MULLEN AM, MCMAHON AC, DAWNAY A: Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension. Am J Hypertens 14:1112-1115, 2001
12. + pump. Clin Sci 95:3-17, 1998
13. 2+ concentrations. J Biol Chem 275:27838-27844, 2000
14. AYDEMIR-KOKSOY A, ABRAMOWITZ J, ALLEN JC: Ouabain-induced signaling and vascular smooth muscle cell proliferation. J Biol Chem 276:46605-46611, 2001
15. ZHU Z, TEPEL M, NEUSSER M, ZIDEK W: Low concentrations of ouabain increase cytosolic free calcium concentration in rat vascular smooth muscle cells. Clin Sci 90:9-12, 1996
16. MANUNTA P, STELLA P, RIVERA R, et al: Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertens 34:450-456, 1999
17. SHIMADA T, NAGASAKA Y, ISHBASHI Y, et al: A probable relationship between an endogenous digitalis-like substance and concentric hypertrophy in primary aldosterone. Intern Med 38:655-659, 1999
18. HAYASHI T, IJIRI Y, TOKO H, et al: Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy. Eur Heart J 21:296-305, 2000
19. HUANG L, LI H, XIE Z: Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression in several late response genes. J Moll Cell Cardiol 29:429-437, 1997
20. SCHMIDT TA, KJELDSEN K: Human myocardial Na,K-ATPase - quantification, regulation and relation to Ca. Cardiovasc Res 37:335-345, 1998